Atlantic

Atlantic Innovo News

Atlantic Therapeutics Raise €28M in Series B Funding

7th January 2019

Seroba portfolio company, Atlantic Therapeutics, has raised €28 million following FDA approval for its INNOVO® therapy device to treat incontinence. This funding facilitates the company’s next growth phase, including geographic expansion to US and other markets, new product launches and […]

Read More
Atlantic Innovo News

Atlantic Therapeutics Secures FDA Approval

13th November 2018

FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence. Galway, Ireland. 13 November 2018. Seroba’s portfolio company, Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, […]

Read More
Gordie Nye News

Atlantic Therapeutics appoints Gordie Nye as Chairman

26th July 2017

Seroba’s investee company, Atlantic Therapeutics, which is focused on treating conditions of the pelvic floor and surrounding tissues, has appointed Gordie Nye as its Chairman. After working with Gillette and Reebok, Gordie Nye forged his career as a CEO and […]

Read More
Atlantic News

Atlantic Therapeutics receives €15 million in funding round

29th March 2017

Atlantic Therapeutics Group Ltd, the Galway-headquartered medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products, has successfully completed a €15 million growth capital financing, enabling it to move forward with its next phase of growth and treat […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top